Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Los Angeles Oral and maxillofacial Surgeon Dr. David Salehani Launches Focused Initiative on Botox Treatment for Muscle-Related TMJ Disorders

Sunset Oral and Facial Surgery

News provided by

Sunset Oral and Facial Surgery

Sep 17, 2026, 12:03 ET

Share this article

Share toX

Share this article

Share toX

Board-certified oral and maxillofacial surgeon aims to increase awareness of how botulinum toxin may help select patients with jaw pain associated with overactive chewing muscles.

WEST HOLLYWOOD, Calif., Sept. 17, 2026 /PRNewswire/ -- David Salehani, DDS, MD, a board-certified oral and maxillofacial surgeon in Los Angeles, has launched a focused initiative to increase awareness of the use of botulinum toxin, commonly known as Botox, as a treatment option for select patients experiencing muscle-related temporomandibular disorders (TMD).

Continue Reading
Sunset Oral Surgery
Sunset Oral Surgery

While Botox is widely associated with cosmetic treatments, botulinum toxin can also be used therapeutically to temporarily reduce excessive muscle activity. For certain patients whose jaw pain is associated with overactivity or tension in the muscles responsible for chewing, targeted treatment of these muscles may help reduce pain and muscle tension.

Dr. Salehani emphasizes, however, that Botox is not appropriate for every patient experiencing what is commonly referred to as "TMJ pain."

"TMJ symptoms can have a number of different causes, so diagnosis has to come before treatment," said Dr. Salehani. "When excessive activity in the chewing muscles is contributing to a patient's pain, Botox may be one option we consider. But the goal is always to identify the underlying source of the symptoms and develop the treatment plan around that individual patient."

TMJ vs. TMD: Why the Distinction Matters

TMJ refers specifically to the temporomandibular joint, the joint connecting the lower jaw to the skull. TMD, or temporomandibular disorder, is a broader term describing conditions involving the jaw joints, chewing muscles and associated structures.

Symptoms can include jaw and facial pain, tenderness in the chewing muscles, headaches, discomfort while chewing, limited jaw movement and clicking or popping of the jaw.

Because similar symptoms can arise from different causes, Dr. Salehani says a comprehensive evaluation is particularly important before considering Botox or another treatment.

Some patients have problems primarily involving the joint itself, while others may have a significant muscular component. Clenching and excessive activation of muscles such as the masseter and temporalis can contribute to muscle tension and discomfort in some patients.

How Botox May Be Used for Muscle-Related TMD

Botulinum toxin works by temporarily reducing nerve signals that cause targeted muscles to contract. When injected into selected chewing muscles, it can decrease the force of muscle contraction for a period of time.

For appropriately selected patients with muscle-related TMD, this reduction in muscle activity may help relieve pain and tension.

Dr. Salehani's approach is not to treat every patient presenting with jaw pain in the same way. Instead, he evaluates the jaw joints, chewing muscles, teeth, bite and surrounding maxillofacial structures to determine which factors may be contributing to the patient's symptoms.

"Botox is a tool, not a diagnosis," said Dr. Salehani. "The important question isn't simply whether someone has jaw pain. It's why they have jaw pain. Once we understand that, we can determine whether Botox or another treatment makes the most sense."

An Oral and Maxillofacial Approach to TMJ Disorders

Dr. Salehani's background provides a particularly comprehensive perspective on conditions affecting the jaw.

He holds both dental and medical degrees and completed specialized training in oral and maxillofacial surgery. His practice encompasses the full scope of oral and maxillofacial surgery, including treatment of TMJ disorders, corrective jaw surgery, facial reconstruction and other conditions involving the jaws and facial structures.

This training allows him to evaluate TMD symptoms within the broader relationship between the teeth, bite, jaw joints, chewing muscles and facial skeleton.

For some patients, conservative approaches may be appropriate before Botox is considered. For others with a significant muscular component to their symptoms, targeted botulinum toxin treatment may be incorporated into an individualized treatment plan.

The growing therapeutic use of botulinum toxin also underscores an important distinction between cosmetic Botox and medically directed treatment of muscle activity.

"Most people hear Botox and immediately think about wrinkles," Dr. Salehani said. "But botulinum toxin affects muscle activity, which is why it can have applications beyond aesthetics. In the right patient, and for the right diagnosis, it can be another option available to us for managing muscle-related jaw pain."

About David Salehani, DDS, MD

David Salehani, DDS, MD, is a board-certified oral and maxillofacial surgeon at Sunset Oral and Facial Surgery in Los Angeles. He received his undergraduate degree in Biochemistry with honors and his Doctor of Dental Surgery with honors from the State University of New York at Stony Brook before earning his medical degree from Stony Brook School of Medicine.

Dr. Salehani completed his Oral and Maxillofacial Surgery training at Long Island Jewish Medical Center and a general surgery internship at Stony Brook University Hospital, where he trained in the management of major trauma cases.

His practice encompasses a full scope of oral and maxillofacial surgery, including TMJ treatment, orthognathic corrective jaw surgery, facial reconstruction, dental implant surgery and aesthetic facial procedures. Dr. Salehani also participates in resident and student education as a faculty member at UCLA Medical Center.

For more information about Dr. David Salehani and treatment of temporomandibular disorders or to schedule an appointment, please visit Sunset Oral and Facial Surgery: https://www.sunsetoralsurgery.com/ or call (310) 275-3635.

For media inquiries, please contact:
Sunset Oral & Facial Surgery
Website: www.sunsetoralsurgery.com

IG: @sunsetoralmaxillofacialsurgery
(310) 275-3635

SOURCE Sunset Oral and Facial Surgery

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Uses Genioplasty (chin surgery) to Address Facial Balance at the Skeletal Level

Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Uses Genioplasty (chin surgery) to Address Facial Balance at the Skeletal Level

When patients are concerned about a weak chin, uneven jawline or an imbalanced facial profile, the chin itself may be only part of the picture. The...

More Releases From This Source

Explore

Dentistry

Dentistry

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.